{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-007459","form_type":"8-K","ticker":"MYO","cik":"0001369290","company_name":"MYOMO, INC.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.648873+00:00","generated_at":"2026-06-18T04:17:29.828505+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Myomo Q4 revenue flat at $4.0M; net loss improves to $0.29/share","bullets":["Q4 product revenue $4.0M, flat YoY and up 2% sequentially; 101 units (down 6% YoY).","Net loss attributable to common stockholders $2.2M ($0.29/share) vs $3.4M ($0.52) prior year.","Gross margin 65.0% (down from 77.4% YoY) due to inflationary costs; operating expenses down 17%.","Patient pipeline added 387 new candidates (+75% YoY); cost per pipeline add down 45% to $2,665.","Jan 2023 workforce cut 12% to save ~$2.0M; guided Q1 product revenue +15-20% YoY, FY +20-30%."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-007459","json":"https://secwatch.observer/filing/0000950170-23-007459.json","markdown":"https://secwatch.observer/filing/0000950170-23-007459.md","text":"https://secwatch.observer/filing/0000950170-23-007459.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369290/000095017023007459/0000950170-23-007459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369290/000095017023007459/myo-20230313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:17:29.828505+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}